MTOR and systemic lupus erythematosus: Additionally, Treg cells effects appear to be significantly modulated in humans compared to mice, which may be explained by the fact that blocking mTOR with rapamycin can complete nephritis blocking in several lupus-susceptible strains without affecting Treg cells in mice.